Patents Assigned to Atrium Medical Corporation
-
Publication number: 20180050132Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: ApplicationFiled: October 26, 2017Publication date: February 22, 2018Applicant: ATRIUM MEDICAL CORPORATIONInventors: Keith M. FAUCHER, Hui TANG, Paul MARTAKOS, Theodore KARWOSKI, Allison SULLIVAN, Greg MELVILLE, Scott E. CORBEIL
-
Publication number: 20180043065Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: ApplicationFiled: October 20, 2017Publication date: February 15, 2018Applicant: ATRIUM MEDICAL CORPORATIONInventors: Keith M. FAUCHER, Hui TANG, Joseph FERRARO, Paul MARTAKOS, Theodore KARWOSKI, Scott CORBEIL
-
Patent number: 9867880Abstract: The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na—CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.Type: GrantFiled: March 15, 2013Date of Patent: January 16, 2018Assignee: Atrium Medical CorporationInventors: Keith M. Faucher, Suzanne Conroy, Theresa K. Albergo, Joseph Bienkiewicz
-
Publication number: 20180008650Abstract: A barrier layer and corresponding method of making provide anti-inflammatory, non-inflammatory, and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing, non-inflammatory, and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.Type: ApplicationFiled: September 20, 2017Publication date: January 11, 2018Applicant: ATRIUM MEDICAL CORPORATIONInventors: Joseph FERRARO, Lisa ROGERS, Paul MARTAKOS, Theodore KARWOSKI, Steve HERWECK, Keith FAUCHER, Phillip MCNAMARA
-
Patent number: 9848971Abstract: A medical device including a mesh prosthesis having a first layer having an opening a second layer secured to the first layer and forming a pocket therebetween. A deployment device is positioned in the pocket and arranged to resiliently exert a deployment force on the mesh prosthesis to urge the mesh prosthesis into a deployment shape. The deployment device has a first shape when deployed that has at least one dimension larger than that of the opening to frustrate removal of the deployment device therethrough. Upon application of a suitable pulling force the deployment device is reconfigurable into a second shape that permits the deployment device to be removed from the pocket through the opening upon application of the suitable pulling force. A method of using a medical device is also included.Type: GrantFiled: February 2, 2015Date of Patent: December 26, 2017Assignee: Atrium Medical CorporationInventors: Anthony R. Horton, David Filipiak, Albert A. Lepage, Jr.
-
Patent number: 9844611Abstract: Exemplary embodiments of the present invention provide adhesion barriers having anti-adhesion and tissue fixating properties. The adhesion barriers are formed of fatty acid based films. The fatty acid-based films may be formed from fatty acid-derived biomaterials. The films may be coated with, or may include, tissue fixating materials to create the adhesion barrier. The adhesion barriers are well tolerated by the body, have anti-inflammation properties, fixate, well to tissue, and have a residence time sufficient to prevent post-surgical adhesions.Type: GrantFiled: January 20, 2016Date of Patent: December 19, 2017Assignee: Atrium Medical CorporationInventors: Thomas M. Swanick, Joe Bienkiewicz, Joseph Ferraro, Paul Martakos, Keith M. Faucher, Alicia Dale
-
Patent number: 9827353Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: GrantFiled: April 20, 2015Date of Patent: November 28, 2017Assignee: Atrium Medical CorporationInventors: Keith M. Faucher, Hui Tang, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Scott E. Corbeil
-
Patent number: 9827352Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: GrantFiled: April 6, 2015Date of Patent: November 28, 2017Assignee: Atrium Medical CorporationInventors: Keith M. Faucher, Hui Tang, Paul Martakos, Theodore Karwoski, Allison Sullivan, Greg Melville, Scott E. Corbeil
-
Patent number: 9820841Abstract: A medical device including a mesh prosthesis having a first mesh layer affixed to a second mesh layer along a perimeter area. An enclosure is defined between the first and second layers and extends inwardly from the perimeter area. An opening in the first layer passes through the first layer to the enclosure. A fixation guide template defines a guide pocket within the enclosure. A resilient deployment structure is removably disposed within the enclosure and extending toward the perimeter area. The resilient deployment structure has an elasticity that generates a resilient deployment force for urging the mesh prosthesis to a deployed configuration from a non-deployed configuration. A shield projection extends outwardly from a perimeter of the resilient deployment structure and is engaged within the guide pocket to prevent relative rotational movement between the resilient deployment structure and the mesh prosthesis. A method of using a medical device is also included.Type: GrantFiled: March 11, 2015Date of Patent: November 21, 2017Assignee: Atrium Medical CorporationInventors: David Filipiak, Albert A. Lepage, Jr.
-
Patent number: 9814807Abstract: A chest drainage system including a collection device configured to receive fluid from the pleural cavity of a patient. A sensor is included to detect a pressure differential in the fluid. A display is configured to display a trend in occurrences of changes in pressure of the fluid over time in predetermined time increments based on a number of detections of pressure differentials that exceed a predetermined pressure differential during each of the predetermined time increments. The trend is correlative to the percentage of time that the patient is deemed to have an air leak in the pleural cavity in the predetermined time increments. The trend is derived from a ratio of the quantity of respiratory cycles of the patient for which the predetermined pressure differential is detected (QRCleak) in the predetermined time increments to the total quantity of respiratory cycles of the patient in respective predetermined time increments (QRCtotal).Type: GrantFiled: March 30, 2015Date of Patent: November 14, 2017Assignee: ATRIUM MEDICAL CORPORATIONInventors: James Croteau, Theodore Karwoski, Joanne Krawczyk, Marc Larochelle, Patrick Lee, Nicholas Want
-
Patent number: 9801913Abstract: A barrier layer and corresponding method of making provide anti-inflammatory, non-inflammatory, and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing, non-inflammatory, and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.Type: GrantFiled: September 28, 2005Date of Patent: October 31, 2017Assignee: ATRIUM MEDICAL CORPORATIONInventors: Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith Faucher, Philip McNamara
-
Patent number: 9801982Abstract: A barrier device is formed of a barrier component that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. The barrier component can be a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The barrier device can have anchoring locations to provide an area on the barrier device to interface with an anchoring mechanism. The anchoring locations can include openings and/or anchor elements. The barrier device can also include truss structures that provide additional strength to the barrier component. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.Type: GrantFiled: March 10, 2008Date of Patent: October 31, 2017Assignee: Atrium Medical CorporationInventors: Steve A. Herweck, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Anthony Richard Horton
-
Patent number: 9713519Abstract: An implantable prosthesis can have a three-dimensional shape that is invertible, so as to assume either a right configuration or a left configuration, which can be substantially mirror images of each other, so as to eliminate the need for separately manufacturing a left prosthesis and a right prosthesis. An implantable prosthesis can be preformed to independently assume a contoured three-dimensional shape that more adequately fits the extraperitoneal laparoscopic inguinal space, while simultaneously maintaining a relatively large area for fixation of the prostheses (e.g., through suturing or integration with the surrounding tissue). An implantable prosthesis can have a three-dimensional contoured shape that is formed from a single piece of continuous material, such as a mesh, and can possess substantially uniform rigidity.Type: GrantFiled: January 4, 2013Date of Patent: July 25, 2017Assignee: Atrium Medical CorporationInventors: Anthony R. Horton, Stephanie M. Santos
-
Patent number: 9682175Abstract: A coating material including a bio-absorbable cross-linked material and a cellular uptake inhibitor. The bio-absorbable cross-linked material includes two or more fatty acids cross-linked into a substantially random configuration by ester bonds. The coating material may be adhered to a medical device. A medical device system including a medical device and a coating is also included.Type: GrantFiled: April 14, 2014Date of Patent: June 20, 2017Assignee: Atrium Medical CorporationInventors: Roger Labrecque, Geoffrey Moodie, Joseph F. Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck
-
Publication number: 20170100228Abstract: A medical device including a first layer having an opening formed therein. A second layer is positioned with respect to the first layer to form a pocket therebetween. A support member is at least partially located in the pocket and reconfigurable for removal of the support member from the pocket via the opening. An affixation element located in the pocket between the support member and the second layer, and secured to the second layer. A method of implanting a medical device is also included.Type: ApplicationFiled: October 8, 2015Publication date: April 13, 2017Applicant: ATRIUM MEDICAL CORPORATIONInventors: David FILIPIAK, Anthony R. HORTON, Albert A. LEPAGE
-
Patent number: 9615907Abstract: An implantable prosthesis device and system for insertion, deployment, and fixation of a hernia prosthesis. The system includes two or more deployment rods removably affixed to the prosthesis. Each rod extends across a majority of a width of the prosthesis and beyond one end of the width of the prosthesis. The rods are arranged generally parallel to one another when in a rolled configuration. The rods are separate, physically noncontiguous wire rods that are not operably coupled to one another. The rods provide structural reinforcement and increased rigidity across the width of the implantable hernia prosthesis while maintaining the ability of the prosthesis to experience bends in its length. In this way, the rods allow a user to separately manipulate discrete portions of the prosthesis while to maintaining the ability of the prosthesis to be rolled up and inserted into the body of a patient through, e.g., a trocar.Type: GrantFiled: March 14, 2013Date of Patent: April 11, 2017Assignee: Atrium Medical CorporationInventor: Anthony R. Horton
-
Patent number: 9592324Abstract: A barrier layer device is formed of an underlying biocompatible structure having a barrier layer coating that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. As implemented herein, the barrier layer is a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The underlying structure can be in the form of a surgical mesh. The barrier device is further provided with reinforced sections or portions to aid with the fastening of the barrier device for implantation purposes and prohibits or substantially reduces the occurrence of excessive stretching and tearing. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.Type: GrantFiled: October 30, 2007Date of Patent: March 14, 2017Assignee: ATRIUM MEDICAL CORPORATIONInventors: Steve A. Herweck, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Anthony Richard Horton
-
Publication number: 20160354579Abstract: A method and apparatus for fluid delivery enables navigation through tortuous, spatially restricted body anatomy to access narrow diameter body lumens for the continuous delivery of fluids, including therapeutic fluids, to the lumen in an atraumatic manner that avoids damage to the body lumen. The fluid delivery device can have a flexible conduit having a proximal end, a distal end, and a lumen extending along an interior of the flexible conduit providing a fluid flow path between the proximal and distal ends, where the lumen transitions into a micro-lumen exiting through a port through which a high concentration of fluid injected into the lumen exits laterally out along an image viewable zone at the distal end of the flexible conduit. The flexible conduit has a maximum outer diameter sized sufficient to navigate narrow diameter body lumens.Type: ApplicationFiled: May 2, 2016Publication date: December 8, 2016Applicant: ATRIUM MEDICAL CORPORATIONInventors: Steve A. HERWECK, Ronit R. FURMAN
-
Publication number: 20160331946Abstract: A chest drainage system, including a circulation assembly having an intake for taking fluid into the system and an exhaust for exhausting fluid out of the system. An intake flow device is configured to selectively control fluid flow through the intake and an exhaust flow device is configured to selectively controlling fluid flow through the exhaust. The circulation assembly has a first configuration and a second configuration such that transitioning between the first and second configurations during operation of the circulation assembly displaces at least a portion of fluid within the system with fluid from outside the system via the intake and the exhaust. A sensor is arranged in fluid communication with the fluid within the system and configured to detect a concentration of a reference fluid in the fluid in the system.Type: ApplicationFiled: May 10, 2016Publication date: November 17, 2016Applicant: ATRIUM MEDICAL CORPORATIONInventors: Wolfram GRZIWA, Greg PEATFIELD
-
Patent number: 9492596Abstract: A barrier layer device is formed of an underlying biocompatible structure having a barrier layer coating that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. As implemented herein, the barrier layer is a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The underlying structure can be in the form of a surgical mesh. The barrier device is further provided with anchoring reinforcements to aid with the fastening of the barrier device for implantation purposes and reinforcing truss sections or portions that prohibit or substantially reduce the occurrence of excessive stretching and tearing. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.Type: GrantFiled: February 2, 2007Date of Patent: November 15, 2016Assignee: ATRIUM MEDICAL CORPORATIONInventors: Steve A. Herweck, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Anthony Richard Horton